1. Home
  2. VYGR vs SPCE Comparison

VYGR vs SPCE Comparison

Compare VYGR & SPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$4.02

Market Cap

226.8M

Sector

Health Care

ML Signal

HOLD

Logo Virgin Galactic Holdings Inc.

SPCE

Virgin Galactic Holdings Inc.

HOLD

Current Price

$3.20

Market Cap

207.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYGR
SPCE
Founded
2013
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Transportation Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
226.8M
207.3M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
VYGR
SPCE
Price
$4.02
$3.20
Analyst Decision
Strong Buy
Hold
Analyst Count
6
6
Target Price
$17.00
$9.22
AVG Volume (30 Days)
375.7K
5.6M
Earning Date
11-10-2025
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$31,316,000.00
$1,661,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$71.78
$2,656.89
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.65
$2.18
52 Week High
$5.96
$6.64

Technical Indicators

Market Signals
Indicator
VYGR
SPCE
Relative Strength Index (RSI) 46.28 43.28
Support Level $3.89 $3.11
Resistance Level $4.19 $3.37
Average True Range (ATR) 0.19 0.23
MACD 0.00 -0.00
Stochastic Oscillator 50.57 11.40

Price Performance

Historical Comparison
VYGR
SPCE

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About SPCE Virgin Galactic Holdings Inc.

Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.

Share on Social Networks: